Carbidopa and Levodopa Enteral Suspension and Ranibizumab Intraocular
Determining the interaction of Carbidopa and Levodopa Enteral Suspension and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbidopa and Levodopa Enteral Suspension-Ranibizumab ophthalmic
- Carbidopa and Levodopa Enteral Suspension-Ranitidine
- Carbidopa and Levodopa Enteral Suspension-Ranitidine Capsule
- Carbidopa and Levodopa Enteral Suspension-Ranitidine Hydrochloride
- Carbidopa and Levodopa Enteral Suspension-Ranitidine Injection
- Carbidopa and Levodopa Enteral Suspension-Ranitidine Suspension
- Ranibizumab Intraocular-Carbidopa and Levodopa Extended-Release Capsules
- Ranibizumab Intraocular-Carbidopa and Levodopa Extended-Release Tablets
- Ranibizumab Intraocular-Carbidopa and Levodopa ODT
- Ranibizumab Intraocular-Carbidopa and Levodopa Orally Disintegrating Tablets
- Ranibizumab Intraocular-Carbidopa and levodopa Route Not Applicable
- Ranibizumab Intraocular-Carbidopa and Levodopa Tablets